We are live on ! Find out more
Baupost Group

Baupost Group Portfolio holdings

AUM $5.05B Turnover 24%
1-Year Est. Return 13.05%
 

Baupost Group invests for the long term in companies and other investments it judges to be undervalued, on behalf of families, foundations, endowments and other institutions. Its philosophy puts risk management first. Seth Klarman, its chief executive and portfolio manager, founded it in 1982 with William Poorvu, a Harvard professor, and partners Howard Stevenson, Jordan Baruch and Isaac Auerbach, and the name is an acronym built from the founders' names. Poorvu supplied the first money to manage, which he had raised by selling his share in a local television station, and Seth Klarman's team ran it. Seth Klarman wrote a 1991 book on value investing, Margin of Safety.

This Fund
S&P 500
This Quarter Est. Return
+2.69%
1 Year Est. Return
+13.05%
3 Year Est. Return
+47.21%
5 Year Est. Return
+23.41%
10 Year Est. Return
+137.34%
AUM
$11B
AUM Growth
-$854M
Cap. Flow
-$1.24B
Cap. Flow %
-11.22%
Top 10 Hldgs %
70.17%
Holding
36
New
1
Increased
8
Reduced
9
Closed
4
Avg Time Held
2.1 years
Top 10 Avg Time Held
1.9 years
Top 20 Avg Time Held
1.7 years

Top Sells

Rank Stock Value
1
CELG
Celgene
CELG
+$377M
2
PXD icon
Pioneer Natural Resources
PXD
+$305M
3
EBAY icon
eBay
EBAY
+$193M
4
SYF icon
Synchrony
SYF
+$169M
5
AGN
Allergan plc
AGN
+$151M

Sector Composition

Rank Sector Weight
1 Communication Services 28.89%
2 Healthcare 22.34%
3 Technology 15.28%
4 Consumer Discretionary 8.63%
5 Energy 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LBTYK icon
1
Liberty Global Class C
LBTYK
$3.43B
$1.11B 10.07%
41,937,674
+2,844,679
+7% +$73.1M
2018 Q3
3 quarters
VSAT icon
2
Viasat
VSAT
$8.9B
$1.11B 10.05%
13,732,068
– –
2013 Q2
24 quarters
FOXA icon
3
Fox Class A
FOXA
$28.1B
$1B 9.06%
27,322,720
– –
2019 Q1
1 quarter
EBAY icon
4
eBay
EBAY
$53.1B
$954M 8.63%
24,146,000
-5,140,000
-18% -$193M
2018 Q4
2 quarters
LNG icon
5
Cheniere Energy
LNG
$61.7B
$731M 6.61%
10,674,135
-1,944,173
-15% -$129M
2014 Q1
21 quarters
AGN
6
DELISTED
Allergan plc
AGN
$616M 5.58%
3,679,549
-1,090,146
-23% -$151M
2016 Q1
13 quarters
BMY icon
7
Bristol-Myers Squibb
BMY
$125B
$590M 5.34%
13,000,000
+9,000,000
+225% +$419M
2019 Q1
1 quarter
QRVO icon
8
DELISTED
Qorvo
QRVO
$578M 5.23%
8,681,181
-1,907,901
-18% -$133M
2017 Q1
9 quarters
PCG icon
9
PG&E
PCG
$29.8B
$562M 5.08%
24,500,000
– –
2018 Q1
5 quarters
PARA icon
10
DELISTED
Paramount Global Class B
PARA
$499M 4.52%
10,000,000
+1,457,984
+17% +$72.2M
2018 Q4
2 quarters
MCK icon
11
McKesson
MCK
$128B
$349M 3.16%
2,595,011
-220,000
-8% -$27.4M
2017 Q3
7 quarters
SYF icon
12
Synchrony
SYF
$22.3B
$321M 2.91%
9,260,557
-5,000,000
-35% -$169M
2016 Q3
11 quarters
DBRG icon
13
DELISTED
DigitalBridge
DBRG
$248M 2.25%
12,421,843
– –
2016 Q3
11 quarters
UNVR
14
DELISTED
Univar Solutions
UNVR
$209M 1.9%
9,500,000
– –
2018 Q3
3 quarters
FOX icon
15
Fox Class B
FOX
$25.6B
$208M 1.88%
5,680,307
– –
2019 Q1
1 quarter
LBTYA icon
16
Liberty Global Class A
LBTYA
$3.5B
$201M 1.82%
7,440,705
+2,483,500
+50% +$65.5M
2018 Q3
3 quarters
COR icon
17
Cencora
COR
$68.1B
$189M 1.71%
2,214,192
-190,107
-8% -$15M
2017 Q3
7 quarters
TAK icon
18
Takeda Pharmaceutical
TAK
$69.1B
$167M 1.51%
9,438,003
-1,231,018
-12% -$22.4M
2019 Q1
1 quarter
AR icon
19
Antero Resources
AR
$11.6B
$158M 1.43%
28,587,791
– –
2014 Q3
19 quarters
TBPH icon
20
DELISTED
Theravance Biopharma
TBPH
$152M 1.38%
9,309,168
– –
2014 Q2
20 quarters
NXST icon
21
Nexstar Media Group
NXST
$6.32B
$141M 1.28%
1,397,755
+397,755
+40% +$42.7M
2018 Q4
2 quarters
ATRA icon
22
Atara Biotherapeutics
ATRA
$65.2M
$141M 1.27%
280,000
+24,779
+10% +$17.5M
2014 Q4
18 quarters
AKBA icon
23
Akebia Therapeutics
AKBA
$111M
$118M 1.07%
24,471,453
– –
2018 Q4
2 quarters
TBIO icon
24
DELISTED
Translate Bio
TBIO
$109M 0.99%
8,844,239
+2,352,941
+36% +$24.8M
2018 Q2
4 quarters
XPO icon
25
XPO
XPO
$22B
$86.7M 0.78%
+4,337,091
New +$88.3M
2019 Q2
0 quarters

Similar funds

Baupost Group's Q2 2019 Portfolio in Review

As of Q2 2019, Baupost Group held 36 positions worth $11B, down 7.2% from $11.9B the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Baupost Group withdrew a net $1.24B in Q2 2019, closing 4 positions and reducing 9 holdings. Its most notable exit was Celgene, an estimated $377M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 29% of assets, up from 25% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Baupost Group opened a new position in XPO worth $86.7M.

  • Baupost Group's largest Q2 2019 buy was XPO: 4,337,091 shares worth $86.7M.
  • Baupost Group added most to Bristol-Myers Squibb in Q2 2019, an estimated $419M increase.
  • Baupost Group's biggest Q2 2019 reduction was eBay, cutting an estimated $193M.
  • Baupost Group fully exited Celgene in Q2 2019, selling an estimated $377M.
  • Baupost Group's ten largest holdings make up 70% of its $11B portfolio in Q2 2019.
  • Baupost Group opened 1 new position and closed 4 in Q2 2019.
  • Baupost Group's portfolio value fell 7.2% quarter-over-quarter to $11B.

Based on Baupost Group's 13F filing for Q2 2019, filed 13 Aug 2019.